McKesson is acquiring US Oncology in a deal valued at $2.16 billion. The combined organization will focus on providing a comprehensive offering of solutions for the oncology industry, they stated. “The unified organization will bring together the collective capabilities of McKesson and US Oncology to provide oncology customers access to: Leading evidence-based medicine offerings that drive continued improvements in clinical outcomes and enable value-based reimbursement; Expanded clinical expertise, clinical research and personalized medicine offerings;
VIDEO: Guerra Lets Fly on HITECH
In early February, I gave my “State of the Industry” presentation at the annual meeting of US Oncology. The Vice President of Informatics Development, Aaron Kaufman, had come across some of my columns and was intrigued by my politically incorrect take on the industry-transforming program. The video below is an honest evaluation of what’s happening […]